Dandekar Atul bought MAZE
August 28, 2026 · Form 4 insider transaction
Dandekar Atul bought 7,500 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $78.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
$10.42
Total value
$78.2K
InsiderDandekar Atul
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 28, 2026
Filing dateAugust 31, 2026
Shares owned after33,750
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.